Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.68 USD | -0.74% | -6.32% | +6.16% |
Financials (USD)
Sales 2024 * | 41.41M | Sales 2025 * | 41.59M | Capitalization | 1.44B |
---|---|---|---|---|---|
Net income 2024 * | -571M | Net income 2025 * | -585M | EV / Sales 2024 * | 16.5 x |
Net cash position 2024 * | 758M | Net cash position 2025 * | 681M | EV / Sales 2025 * | 18.3 x |
P/E ratio 2024 * |
-2.54
x | P/E ratio 2025 * |
-2.69
x | Employees | 587 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.39% |
Latest transcript on Vir Biotechnology, Inc.
1 day | -0.74% | ||
1 week | -6.32% | ||
Current month | -4.98% | ||
1 month | +4.20% | ||
3 months | +9.88% | ||
6 months | +10.90% | ||
Current year | +6.16% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 56 | - | |
Sung Lee
DFI | Director of Finance/CFO | 53 | 23-03-26 |
Jennifer Towne
CTO | Chief Tech/Sci/R&D Officer | - | Nov. 05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Charles Sigal
BRD | Director/Board Member | 72 | 20-07-01 |
Robert Perez
BRD | Director/Board Member | 59 | 16-12-31 |
Robert More
BRD | Director/Board Member | 56 | 16-08-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
12.90% | 227 M€ | +9.20% | - | |
0.63% | 29 M€ | -3.85% | ||
0.58% | 26 M€ | -3.34% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-18 | 10.68 | -0.74% | 1,111,567 |
24-03-15 | 10.76 | +2.28% | 1,911,580 |
24-03-14 | 10.52 | -3.93% | 1,086,181 |
24-03-13 | 10.95 | +2.05% | 1,064,884 |
24-03-12 | 10.73 | -5.88% | 970,457 |
Delayed Quote Nasdaq, March 18, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.16% | 1.44B | |
+9.72% | 46.21B | |
+34.72% | 40.04B | |
+4.84% | 39.92B | |
-9.43% | 28.33B | |
+17.47% | 27.43B | |
-22.99% | 18.57B | |
+10.88% | 13.46B | |
+27.53% | 12.02B | |
-6.84% | 11.3B |